RT Book, Section
A1 Tang, Andrew
A1 Ahmad, Usman
A1 Murthy, Sudish C.
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Burt, Bryan M.
A2 Groth, Shawn S.
A2 Loor, Gabriel
A2 Wolf, Andrea S.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1170408939
T1 Endoscopic Treatments for Benign Major Upper Airways Disease
T2 Sugarbaker’s Adult Chest Surgery, 3e
YR 2020
FD 2020
PB McGraw-Hill Education
PP New York, NY
SN 9781260026931
LK accesssurgery.mhmedical.com/content.aspx?aid=1170408939
RD 2024/04/20
AB In  highly  selected  patient  populations,  flexible  and  rigid  endoscopic  (endobronchial)  management  offers  effective  treatment  options  for  benign  major  airway  disease  (e.g.,  stenosis  and  malacia).  These  treatments  are  associated  with  less  morbidity  than  traditional  open  surgical  interventions.  Selection  criteria  focus  primarily  on  candidacy  for  more  definitive  surgical  therapy,  as  patients  can  be  deemed  inappropriate  candidates  for  classic  resection/reconstruction  for  a  variety  of  reasons:  etiology,  extent  of  disease,  failed  prior  operation,  confounding  medical  comorbidities,  and  patient  preference.  Lack  of  technical  expertise  at  a  given  institution  also  may  be  a  factor.  Since  each  institution  carries  its  own  bias  with  respect  to  these  parameters,  a  patient  determined  inoperable  at  one  center,  in  fact,  may  be  considered  a  reasonable  candidate  at  another.